Global Artificial Pancreas Devices Systems Market Size, Manufacturers, Opportunities and Forecast to 2030
The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a 'closed-loop' system, an 'automated insulin delivery' system, or an 'autonomous system for glycemic control.'
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
According to APO Research, The global Artificial Pancreas Devices Systems market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Medtronic monopolizes the global Artificial Pancreas Devices Systems market, holding a share about 100%.
North America is the largest market, with a share about 60%, followed by Europe, have a share about 30 percent.
In terms of product, Threshold Suspended Device Systems is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospitals
, followed by Clinics.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Artificial Pancreas Devices Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Pancreas Devices Systems.
The Artificial Pancreas Devices Systems market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Pancreas Devices Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Pancreas Devices Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artificial Pancreas Devices Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Pancreas Devices Systems.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Pancreas Devices Systems manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Artificial Pancreas Devices Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a 'closed-loop' system, an 'automated insulin delivery' system, or an 'autonomous system for glycemic control.'
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
According to APO Research, The global Artificial Pancreas Devices Systems market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Medtronic monopolizes the global Artificial Pancreas Devices Systems market, holding a share about 100%.
North America is the largest market, with a share about 60%, followed by Europe, have a share about 30 percent.
In terms of product, Threshold Suspended Device Systems is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospitals
, followed by Clinics.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Artificial Pancreas Devices Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Pancreas Devices Systems.
The Artificial Pancreas Devices Systems market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Pancreas Devices Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Medtronic
- Bigfoot Biomedical
- Beta Bionics
- Admetsys
- Insulet
- Tandem Diabetes Care
- Defymed
- Threshold Suspended Device Systems
- Hybrid Closed-loop APDS
- Other Systems
- Hospitals
- Clinics
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Pancreas Devices Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artificial Pancreas Devices Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Pancreas Devices Systems.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Pancreas Devices Systems manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Artificial Pancreas Devices Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Artificial Pancreas Devices Systems Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Artificial Pancreas Devices Systems Sales Estimates and Forecasts (2019-2030)
1.3 Artificial Pancreas Devices Systems Market by Type
1.3.1 Threshold Suspended Device Systems
1.3.2 Hybrid Closed-loop APDS
1.3.3 Other Systems
1.4 Global Artificial Pancreas Devices Systems Market Size by Type
1.4.1 Global Artificial Pancreas Devices Systems Market Size Overview by Type (2019-2030)
1.4.2 Global Artificial Pancreas Devices Systems Historic Market Size Review by Type (2019-2024)
1.4.3 Global Artificial Pancreas Devices Systems Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Artificial Pancreas Devices Systems Sales Breakdown by Type (2019-2024)
1.5.2 Europe Artificial Pancreas Devices Systems Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Artificial Pancreas Devices Systems Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Artificial Pancreas Devices Systems Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Artificial Pancreas Devices Systems Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Artificial Pancreas Devices Systems Industry Trends
2.2 Artificial Pancreas Devices Systems Industry Drivers
2.3 Artificial Pancreas Devices Systems Industry Opportunities and Challenges
2.4 Artificial Pancreas Devices Systems Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Artificial Pancreas Devices Systems Revenue (2019-2024)
3.2 Global Top Players by Artificial Pancreas Devices Systems Sales (2019-2024)
3.3 Global Top Players by Artificial Pancreas Devices Systems Price (2019-2024)
3.4 Global Artificial Pancreas Devices Systems Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Artificial Pancreas Devices Systems Key Company Manufacturing Sites & Headquarters
3.6 Global Artificial Pancreas Devices Systems Company, Product Type & Application
3.7 Global Artificial Pancreas Devices Systems Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Artificial Pancreas Devices Systems Market CR5 and HHI
3.8.2 Global Top 5 and 10 Artificial Pancreas Devices Systems Players Market Share by Revenue in 2023
3.8.3 2023 Artificial Pancreas Devices Systems Tier 1, Tier 2, and Tier
4 ARTIFICIAL PANCREAS DEVICES SYSTEMS REGIONAL STATUS AND OUTLOOK
4.1 Global Artificial Pancreas Devices Systems Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Artificial Pancreas Devices Systems Historic Market Size by Region
4.2.1 Global Artificial Pancreas Devices Systems Sales in Volume by Region (2019-2024)
4.2.2 Global Artificial Pancreas Devices Systems Sales in Value by Region (2019-2024)
4.2.3 Global Artificial Pancreas Devices Systems Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Artificial Pancreas Devices Systems Forecasted Market Size by Region
4.3.1 Global Artificial Pancreas Devices Systems Sales in Volume by Region (2025-2030)
4.3.2 Global Artificial Pancreas Devices Systems Sales in Value by Region (2025-2030)
4.3.3 Global Artificial Pancreas Devices Systems Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 ARTIFICIAL PANCREAS DEVICES SYSTEMS BY APPLICATION
5.1 Artificial Pancreas Devices Systems Market by Application
5.1.1 Hospitals
5.1.2 Clinics
5.2 Global Artificial Pancreas Devices Systems Market Size by Application
5.2.1 Global Artificial Pancreas Devices Systems Market Size Overview by Application (2019-2030)
5.2.2 Global Artificial Pancreas Devices Systems Historic Market Size Review by Application (2019-2024)
5.2.3 Global Artificial Pancreas Devices Systems Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Artificial Pancreas Devices Systems Sales Breakdown by Application (2019-2024)
5.3.2 Europe Artificial Pancreas Devices Systems Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Artificial Pancreas Devices Systems Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Artificial Pancreas Devices Systems Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Artificial Pancreas Devices Systems Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Medtronic
6.1.1 Medtronic Comapny Information
6.1.2 Medtronic Business Overview
6.1.3 Medtronic Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic Artificial Pancreas Devices Systems Product Portfolio
6.1.5 Medtronic Recent Developments
6.2 Bigfoot Biomedical
6.2.1 Bigfoot Biomedical Comapny Information
6.2.2 Bigfoot Biomedical Business Overview
6.2.3 Bigfoot Biomedical Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bigfoot Biomedical Artificial Pancreas Devices Systems Product Portfolio
6.2.5 Bigfoot Biomedical Recent Developments
6.3 Beta Bionics
6.3.1 Beta Bionics Comapny Information
6.3.2 Beta Bionics Business Overview
6.3.3 Beta Bionics Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Beta Bionics Artificial Pancreas Devices Systems Product Portfolio
6.3.5 Beta Bionics Recent Developments
6.4 Admetsys
6.4.1 Admetsys Comapny Information
6.4.2 Admetsys Business Overview
6.4.3 Admetsys Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Admetsys Artificial Pancreas Devices Systems Product Portfolio
6.4.5 Admetsys Recent Developments
6.5 Insulet
6.5.1 Insulet Comapny Information
6.5.2 Insulet Business Overview
6.5.3 Insulet Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Insulet Artificial Pancreas Devices Systems Product Portfolio
6.5.5 Insulet Recent Developments
6.6 Tandem Diabetes Care
6.6.1 Tandem Diabetes Care Comapny Information
6.6.2 Tandem Diabetes Care Business Overview
6.6.3 Tandem Diabetes Care Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Tandem Diabetes Care Artificial Pancreas Devices Systems Product Portfolio
6.6.5 Tandem Diabetes Care Recent Developments
6.7 Defymed
6.7.1 Defymed Comapny Information
6.7.2 Defymed Business Overview
6.7.3 Defymed Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Defymed Artificial Pancreas Devices Systems Product Portfolio
6.7.5 Defymed Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Artificial Pancreas Devices Systems Sales by Country
7.1.1 North America Artificial Pancreas Devices Systems Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Artificial Pancreas Devices Systems Sales by Country (2019-2024)
7.1.3 North America Artificial Pancreas Devices Systems Sales Forecast by Country (2025-2030)
7.2 North America Artificial Pancreas Devices Systems Market Size by Country
7.2.1 North America Artificial Pancreas Devices Systems Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Artificial Pancreas Devices Systems Market Size by Country (2019-2024)
7.2.3 North America Artificial Pancreas Devices Systems Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Artificial Pancreas Devices Systems Sales by Country
8.1.1 Europe Artificial Pancreas Devices Systems Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Artificial Pancreas Devices Systems Sales by Country (2019-2024)
8.1.3 Europe Artificial Pancreas Devices Systems Sales Forecast by Country (2025-2030)
8.2 Europe Artificial Pancreas Devices Systems Market Size by Country
8.2.1 Europe Artificial Pancreas Devices Systems Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Artificial Pancreas Devices Systems Market Size by Country (2019-2024)
8.2.3 Europe Artificial Pancreas Devices Systems Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Artificial Pancreas Devices Systems Sales by Country
9.1.1 Asia-Pacific Artificial Pancreas Devices Systems Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Artificial Pancreas Devices Systems Sales by Country (2019-2024)
9.1.3 Asia-Pacific Artificial Pancreas Devices Systems Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Artificial Pancreas Devices Systems Market Size by Country
9.2.1 Asia-Pacific Artificial Pancreas Devices Systems Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Artificial Pancreas Devices Systems Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Artificial Pancreas Devices Systems Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Artificial Pancreas Devices Systems Sales by Country
10.1.1 Latin America Artificial Pancreas Devices Systems Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Artificial Pancreas Devices Systems Sales by Country (2019-2024)
10.1.3 Latin America Artificial Pancreas Devices Systems Sales Forecast by Country (2025-2030)
10.2 Latin America Artificial Pancreas Devices Systems Market Size by Country
10.2.1 Latin America Artificial Pancreas Devices Systems Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Artificial Pancreas Devices Systems Market Size by Country (2019-2024)
10.2.3 Latin America Artificial Pancreas Devices Systems Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Artificial Pancreas Devices Systems Sales by Country
11.1.1 Middle East and Africa Artificial Pancreas Devices Systems Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Artificial Pancreas Devices Systems Sales by Country (2019-2024)
11.1.3 Middle East and Africa Artificial Pancreas Devices Systems Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Artificial Pancreas Devices Systems Market Size by Country
11.2.1 Middle East and Africa Artificial Pancreas Devices Systems Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Artificial Pancreas Devices Systems Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Artificial Pancreas Devices Systems Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Artificial Pancreas Devices Systems Value Chain Analysis
12.1.1 Artificial Pancreas Devices Systems Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Artificial Pancreas Devices Systems Production Mode & Process
12.2 Artificial Pancreas Devices Systems Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Artificial Pancreas Devices Systems Distributors
12.2.3 Artificial Pancreas Devices Systems Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Artificial Pancreas Devices Systems Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Artificial Pancreas Devices Systems Sales Estimates and Forecasts (2019-2030)
1.3 Artificial Pancreas Devices Systems Market by Type
1.3.1 Threshold Suspended Device Systems
1.3.2 Hybrid Closed-loop APDS
1.3.3 Other Systems
1.4 Global Artificial Pancreas Devices Systems Market Size by Type
1.4.1 Global Artificial Pancreas Devices Systems Market Size Overview by Type (2019-2030)
1.4.2 Global Artificial Pancreas Devices Systems Historic Market Size Review by Type (2019-2024)
1.4.3 Global Artificial Pancreas Devices Systems Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Artificial Pancreas Devices Systems Sales Breakdown by Type (2019-2024)
1.5.2 Europe Artificial Pancreas Devices Systems Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Artificial Pancreas Devices Systems Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Artificial Pancreas Devices Systems Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Artificial Pancreas Devices Systems Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Artificial Pancreas Devices Systems Industry Trends
2.2 Artificial Pancreas Devices Systems Industry Drivers
2.3 Artificial Pancreas Devices Systems Industry Opportunities and Challenges
2.4 Artificial Pancreas Devices Systems Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Artificial Pancreas Devices Systems Revenue (2019-2024)
3.2 Global Top Players by Artificial Pancreas Devices Systems Sales (2019-2024)
3.3 Global Top Players by Artificial Pancreas Devices Systems Price (2019-2024)
3.4 Global Artificial Pancreas Devices Systems Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Artificial Pancreas Devices Systems Key Company Manufacturing Sites & Headquarters
3.6 Global Artificial Pancreas Devices Systems Company, Product Type & Application
3.7 Global Artificial Pancreas Devices Systems Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Artificial Pancreas Devices Systems Market CR5 and HHI
3.8.2 Global Top 5 and 10 Artificial Pancreas Devices Systems Players Market Share by Revenue in 2023
3.8.3 2023 Artificial Pancreas Devices Systems Tier 1, Tier 2, and Tier
4 ARTIFICIAL PANCREAS DEVICES SYSTEMS REGIONAL STATUS AND OUTLOOK
4.1 Global Artificial Pancreas Devices Systems Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Artificial Pancreas Devices Systems Historic Market Size by Region
4.2.1 Global Artificial Pancreas Devices Systems Sales in Volume by Region (2019-2024)
4.2.2 Global Artificial Pancreas Devices Systems Sales in Value by Region (2019-2024)
4.2.3 Global Artificial Pancreas Devices Systems Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Artificial Pancreas Devices Systems Forecasted Market Size by Region
4.3.1 Global Artificial Pancreas Devices Systems Sales in Volume by Region (2025-2030)
4.3.2 Global Artificial Pancreas Devices Systems Sales in Value by Region (2025-2030)
4.3.3 Global Artificial Pancreas Devices Systems Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 ARTIFICIAL PANCREAS DEVICES SYSTEMS BY APPLICATION
5.1 Artificial Pancreas Devices Systems Market by Application
5.1.1 Hospitals
5.1.2 Clinics
5.2 Global Artificial Pancreas Devices Systems Market Size by Application
5.2.1 Global Artificial Pancreas Devices Systems Market Size Overview by Application (2019-2030)
5.2.2 Global Artificial Pancreas Devices Systems Historic Market Size Review by Application (2019-2024)
5.2.3 Global Artificial Pancreas Devices Systems Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Artificial Pancreas Devices Systems Sales Breakdown by Application (2019-2024)
5.3.2 Europe Artificial Pancreas Devices Systems Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Artificial Pancreas Devices Systems Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Artificial Pancreas Devices Systems Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Artificial Pancreas Devices Systems Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Medtronic
6.1.1 Medtronic Comapny Information
6.1.2 Medtronic Business Overview
6.1.3 Medtronic Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic Artificial Pancreas Devices Systems Product Portfolio
6.1.5 Medtronic Recent Developments
6.2 Bigfoot Biomedical
6.2.1 Bigfoot Biomedical Comapny Information
6.2.2 Bigfoot Biomedical Business Overview
6.2.3 Bigfoot Biomedical Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bigfoot Biomedical Artificial Pancreas Devices Systems Product Portfolio
6.2.5 Bigfoot Biomedical Recent Developments
6.3 Beta Bionics
6.3.1 Beta Bionics Comapny Information
6.3.2 Beta Bionics Business Overview
6.3.3 Beta Bionics Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Beta Bionics Artificial Pancreas Devices Systems Product Portfolio
6.3.5 Beta Bionics Recent Developments
6.4 Admetsys
6.4.1 Admetsys Comapny Information
6.4.2 Admetsys Business Overview
6.4.3 Admetsys Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Admetsys Artificial Pancreas Devices Systems Product Portfolio
6.4.5 Admetsys Recent Developments
6.5 Insulet
6.5.1 Insulet Comapny Information
6.5.2 Insulet Business Overview
6.5.3 Insulet Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Insulet Artificial Pancreas Devices Systems Product Portfolio
6.5.5 Insulet Recent Developments
6.6 Tandem Diabetes Care
6.6.1 Tandem Diabetes Care Comapny Information
6.6.2 Tandem Diabetes Care Business Overview
6.6.3 Tandem Diabetes Care Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Tandem Diabetes Care Artificial Pancreas Devices Systems Product Portfolio
6.6.5 Tandem Diabetes Care Recent Developments
6.7 Defymed
6.7.1 Defymed Comapny Information
6.7.2 Defymed Business Overview
6.7.3 Defymed Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Defymed Artificial Pancreas Devices Systems Product Portfolio
6.7.5 Defymed Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Artificial Pancreas Devices Systems Sales by Country
7.1.1 North America Artificial Pancreas Devices Systems Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Artificial Pancreas Devices Systems Sales by Country (2019-2024)
7.1.3 North America Artificial Pancreas Devices Systems Sales Forecast by Country (2025-2030)
7.2 North America Artificial Pancreas Devices Systems Market Size by Country
7.2.1 North America Artificial Pancreas Devices Systems Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Artificial Pancreas Devices Systems Market Size by Country (2019-2024)
7.2.3 North America Artificial Pancreas Devices Systems Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Artificial Pancreas Devices Systems Sales by Country
8.1.1 Europe Artificial Pancreas Devices Systems Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Artificial Pancreas Devices Systems Sales by Country (2019-2024)
8.1.3 Europe Artificial Pancreas Devices Systems Sales Forecast by Country (2025-2030)
8.2 Europe Artificial Pancreas Devices Systems Market Size by Country
8.2.1 Europe Artificial Pancreas Devices Systems Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Artificial Pancreas Devices Systems Market Size by Country (2019-2024)
8.2.3 Europe Artificial Pancreas Devices Systems Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Artificial Pancreas Devices Systems Sales by Country
9.1.1 Asia-Pacific Artificial Pancreas Devices Systems Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Artificial Pancreas Devices Systems Sales by Country (2019-2024)
9.1.3 Asia-Pacific Artificial Pancreas Devices Systems Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Artificial Pancreas Devices Systems Market Size by Country
9.2.1 Asia-Pacific Artificial Pancreas Devices Systems Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Artificial Pancreas Devices Systems Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Artificial Pancreas Devices Systems Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Artificial Pancreas Devices Systems Sales by Country
10.1.1 Latin America Artificial Pancreas Devices Systems Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Artificial Pancreas Devices Systems Sales by Country (2019-2024)
10.1.3 Latin America Artificial Pancreas Devices Systems Sales Forecast by Country (2025-2030)
10.2 Latin America Artificial Pancreas Devices Systems Market Size by Country
10.2.1 Latin America Artificial Pancreas Devices Systems Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Artificial Pancreas Devices Systems Market Size by Country (2019-2024)
10.2.3 Latin America Artificial Pancreas Devices Systems Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Artificial Pancreas Devices Systems Sales by Country
11.1.1 Middle East and Africa Artificial Pancreas Devices Systems Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Artificial Pancreas Devices Systems Sales by Country (2019-2024)
11.1.3 Middle East and Africa Artificial Pancreas Devices Systems Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Artificial Pancreas Devices Systems Market Size by Country
11.2.1 Middle East and Africa Artificial Pancreas Devices Systems Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Artificial Pancreas Devices Systems Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Artificial Pancreas Devices Systems Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Artificial Pancreas Devices Systems Value Chain Analysis
12.1.1 Artificial Pancreas Devices Systems Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Artificial Pancreas Devices Systems Production Mode & Process
12.2 Artificial Pancreas Devices Systems Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Artificial Pancreas Devices Systems Distributors
12.2.3 Artificial Pancreas Devices Systems Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
